Study design and setting
MAY, APPENDIX
A cluster-randomized, two-period, crossover trial was conducted from February 17, 2021 to May 31, 2021, to evaluate the value of an intensified SARS-CoV-2 screening strategy combining nurse-driven screening for asymptomatic/paucisymptomatic patients with routine screening practice (intervention) compared to routine screening practice alone (control) in 18 EDs. Routine screening practice included screening symptomatic or hospitalized patients. The protocol of the ANRS|MIE DEPIST-COVID trial is available in Appendix A in The Paris metropolitan region, divided into 8 geographical departments, includes more than 12 million people [